Services search (in the department)
| Illness | Number of cases |
|---|---|
| Malignant neoplasm of prostate (C61) | 51 |
| Benign neoplasm of male genital organs - Benign neoplasm of prostate (D29.1) | 46 |
| Hyperplasia of prostate (N40) | 13 |
| Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8) | 9 |
| Calculus of kidney and ureter - Calculus of kidney (N20.0) | 9 |
| Calculus of kidney and ureter - Calculus of ureter (N20.1) | 8 |
| Redundant prepuce phimosis and paraphimosis (N47) | 8 |
| Malignant neoplasm of bladder - Malignant neoplasm of bladder unspecified (C67.9) | 4 |
| Malignant neoplasm of bladder - Malignant neoplasm of trigone of bladder (C67.0) | not specified |
| Non-follicular lymphoma (C83.0) | not specified |
| Treatment | Number |
|---|---|
| Taking a tissue sample (biopsy) of the male reproductive organs through the rectum (1-464.01) | 51 |
| Injection or administration of medicines into the urinary bladder (8-132.3) | 44 |
| Treatment of rectal bleeding by packing with absorbent material (tamponade) (8-502) | 41 |
| Image fusion from different imaging sources on a computer (3-997) | 40 |
| (1-466.01) | 23 |
| Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40) | 21 |
| Surgical removal or destruction of prostatic tissue through the urethra (5-601.1) | 17 |
| Instillation into a body cavity and locally restricted treatment with chemotherapy drugs or agents that influence the immune system (8-541.4) | 13 |
| (1-465.91) | 12 |
| Additional information for investigations (1-999.02) | 11 |
Department key: 2200
Inpatient department
| Bezeichnung | |
| Teilnahme externe Qualitätssicherung | 0 |
| Number | Group |
|---|---|
| 26 | Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training* |
| 17 | Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence |
| 17 | Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations |
| Job | Explanation |
|---|---|
| Student training (clinical traineeship / internship year) | Famulaturen, Klinikstudent (finanzielle Förderung ab dem 5. Semester). Die Region Altmühlfranken ist Partner im Programm „Beste Landpartie Allgemeinmedizin“ (BeLA Nord). Das Klinikum Altmühlfranken ist als Teil des Projekts akademisches Lehrkrankenhaus der Universität Erlangen. |
| No. | Training in other healing professions | Comment |
|---|---|---|
| HB12 | Medical technical laboratory assistant (MTLA) (m/f) | in Kooperation mit der Berufsfachschule |
| HB05 | Medical technical radiology assistant (MTRA) (m/f) | |
| HB19 | Nursing professionals | |
| HB07 | Surgical technical assistant (m/f) | in Kooperation mit Klinikum Fürth |
| HB17 | Auxiliary nurse (m/f) |
Gitta Edel-Kirste
Assistenz Vorstand
Phone:
09831
-52-2000
Mail:
ed.neknarflheumtla-mukinilk@NUG-tnemeganamsgnunieM
Eileen Zäh
Assistenz kfm. Direktor
Phone:
09141
-903-3000
Mail:
ed.neknarflheumtla-mukinilk@GUW-tnemeganamsgnunieM
Katja Schmidt
Qualitätsmanagementbeauftragte
Phone:
09141
-903-3812
Mail:
ed.neknarflheumtla-mukinilk@tdimhcs.ajtak
Dr. Christian Maune
Ärztlicher Direktor
Phone:
09141
-903-3110
Mail:
ed.neknarflheumtla-mukinilk@enuam.naitsirhc
Dr. Christian Maune
Ärztlicher Direktor, Vorsitzender der Arzneimittelkommission
Phone:
09141
-903-3110
Mail:
ed.neknarflheumtla-mukinilk@enuam.naitsirhc